Literature DB >> 6275094

Proteins Specified by bovine herpesvirus 1 (infectious bovine rhinotracheitis virus).

V Misra, R M Blumenthal, L A Babiuk.   

Abstract

An electrophoretic analysis of radioactively labeled, purified, "empty" and DNA-containing infectious bovine rhinotracheitis virions revealed the presence of 25 to 33 structural (virion) polypeptides. A total of 11 of these polypeptides could be labeled with [3H]glucosamine and were identified as glycoproteins. In addition to the 25 structural polypeptides, infectious bovine rhinotracheitis virus infected cells also contained at least 15 nonstructural (nonvirion) polypeptides that were not present in purified virions. Expression of the viral polypeptides in infected cells was controlled temporally. Thus, most viral polypeptides could be categorized as "alpha" (immediate early), "beta" (early), or "gamma" (late) on the basis of their order of appearance in infected cells and whether their syntheses were dependent upon prior viral protein or DNA synthesis. None of the glycoproteins belongs to the alpha class, although at least one (GVP11) was synthesized in the absence of viral DNA synthesis. Serum from a cow in which infectious bovine rhinotracheitis virus lesions were reactivated by dexamethasone precipitated both structural and nonstructural polypeptides.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6275094      PMCID: PMC256637     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Herpes simplex virus glycoproteins: participation of individual herpes simplex virus type 1 glycoprotein antigens in immunocytolysis and their correlation with previously identified glycopolypeptides.

Authors:  B Norrild; S L Shore; A J Nahmias
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

2.  Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells.

Authors:  P G Spear
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

3.  DNA-binding proteins induced by herpes simplex virus type 2 in HEp-2 cells.

Authors:  D J Purifoy; K L Powell
Journal:  J Virol       Date:  1976-08       Impact factor: 5.103

4.  Sequence of protein synthesis in cells infected by human cytomegalovirus: early and late virus-induced polypeptides.

Authors:  M F Stinski
Journal:  J Virol       Date:  1978-06       Impact factor: 5.103

5.  Proteins of murine cytomegalovirus: identification of structural and nonstructural antigens in infected cells.

Authors:  J K Chantler; J B Hudson
Journal:  Virology       Date:  1978-05-01       Impact factor: 3.616

6.  The enumeration of viral genomes in murine cytomegalovirus-infected cells.

Authors:  V Misra; M T Muller; J B Hudson
Journal:  Virology       Date:  1977-12       Impact factor: 3.616

7.  Regulation of murine cytomegalovirus gene expression. I. Transcription during productive infection.

Authors:  V Misra; M T Muller; J K Chantler; J B Hudson
Journal:  J Virol       Date:  1978-08       Impact factor: 5.103

Review 8.  Mechanisms of recovery from Herpesvirus infections -a review.

Authors:  B T Rouse; L A Babiuk
Journal:  Can J Comp Med       Date:  1978-10

9.  Two dimensional gel electrophoresis and computer analysis of proteins synthesized by clonal cell lines.

Authors:  J I Garrels
Journal:  J Biol Chem       Date:  1979-08-25       Impact factor: 5.157

10.  Biogenesis of vaccinia: evidence for more than 100 polypeptides in the virion.

Authors:  K Essani; S Dales
Journal:  Virology       Date:  1979-06       Impact factor: 3.616

View more
  55 in total

1.  Spatial and temporal distribution of bovine herpesvirus 1 transcripts.

Authors:  U V Wirth; K Gunkel; M Engels; M Schwyzer
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

2.  The three major immediate-early transcripts of bovine herpesvirus 1 arise from two divergent and spliced transcription units.

Authors:  U V Wirth; B Vogt; M Schwyzer
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

3.  Expression of glycoprotein gIII-human decay-accelerating factor chimera on the bovine herpesvirus 1 virion via a glycosyl phosphatidylinositol-based membrane anchor.

Authors:  X Liang; M Tang; T J Zamb; L A Babiuk; J Kowalski; M L Tykocinski
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

4.  Identification of a novel bovine herpesvirus type 1 immediate-early infected cell protein.

Authors:  M K Hayes; D L Rock
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

5.  Gene mapping of infectious bovine rhinotracheitis viral DNA genome.

Authors:  C Simard; F Nadon; C Séguin; S LaBoissière; M Trudel
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

6.  Immune response to bovine herpes herpesvirus type 1 infections: virus-specific antibodies in sera from infected animals.

Authors:  J K Collins; A C Butcher; C A Riegel
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

7.  Comparison of the primate alphaherpesviruses. I. Characterization of two herpesviruses from spider monkeys and squirrel monkeys and viral polypeptides synthesized in infected cells.

Authors:  S W Mou; J K Hilliard; C H Song; R Eberle
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

8.  Protein and DNA elements involved in transactivation of the promoter of the bovine herpesvirus (BHV) 1 IE-1 transcription unit by the BHV alpha gene trans-inducing factor.

Authors:  V Misra; A C Bratanich; D Carpenter; P O'Hare
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Identification of the bovine herpesvirus 1 circ protein, a myristylated and virion-associated polypeptide which is not essential for virus replication in cell culture.

Authors:  C Fraefel; M Ackermann; M Schwyzer
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Bovine herpesvirus 1 attachment to permissive cells is mediated by its major glycoproteins gI, gIII, and gIV.

Authors:  X P Liang; L A Babiuk; S van Drunen Littel-van den Hurk; D R Fitzpatrick; T J Zamb
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.